NPTX-204

NPTX-204 is an investigational **small molecule** lipid-based neuroprotective pharmaceutical being developed by **Neuropathix**. Public descriptions characterize it as a pharmaceutical composition comprising **phosphatidylcholine containing long-chain polyunsaturated fatty acids**, reportedly inspired by compounds from **hops**. Preclinical in vitro studies in hippocampal neuron cultures exposed to severe ethanol toxicity found that NPTX-204 maintained neuronal viability and reduced neuronal cell death, with the intended therapeutic concept being protection of central nervous system neuronal tissue from **oxidative stress**. Its mechanism is described functionally as neuronal cytoprotection against oxidative injury rather than through a clearly disclosed single molecular target, and the program appears to remain at the **preclinical or in-development** stage.